Dan Jones and the IC team unpack results from a retailer, what investors can learn from 25 years of volatility, and the ...

hVIVO (HVO:7.75p) has announced a significant contract cancellation alongside a postponement and a smaller study cancellation that has led to material earnings downgrades. The company is a specialist ...

Takeovers and mergers are a natural part of life on the market. It makes sense for companies to buy or merge with competitors ...

Sensibly, management has been carefully managing costs and is maintaining tight control over working capital. Net cash ...

Arguably, one company that fits this description is speciality polymers manufacturer Victrex (VCT), which is the world’s ...

Having recently appointed a new chief executive, Raffi Stepanian, the medical technology company is building real sales ...

Led by a team who made their name at turnaround specialist Hilco, the group is acquiring undervalued SME businesses at favourable prices by providing an exit to their founders. Moreover, by focusing ...

In terms of the fiscal landscape, the Labour government announced (October 2024) an increase in the tax rate on North Sea oil ...

The figures for the year to 31 March were in line with the prior warning. Revenue grew 1 per cent (2 per cent organically) to £1.93bn, with growth driven by the UK and Australia as US sales fell 13 ...

Ultimately, a narrowing of the 70 per cent share price discount to NAV is dependent on an improvement in property investment ...

The US drugmaker has stolen a march on Novo Nordisk by bringing a viable oral weight-loss medicine, orforglipron, into successful phase 3 clinical trials. An oral version is the holy grail for drugs ...

Five months into an unsettling year for markets, the Bearbull Income Portfolio is up by 3.3 per cent.